Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
Schizophrenia Bulletin · 2024
DOI: 10.1093/schbul/sbae034 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Schizophrenia Bulletin, 2024. Verfasst von Alexander Denissoff und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Antipsychotic Agents, Psychotic Disorders, Hospitalization, Marijuana Abuse. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council.
Abstract (Originalsprache)
Background and Hypothesis There is a paucity of research on treatment outcomes of patients with psychosis and cannabis use disorder (CUD). We aimed to compare the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis (FEP) and co-occurring CUD. Study Design We utilized a nationwide Swedish cohort of patients with longitudinal register data from the year 2006 to 2021. Participants were patients with FEP and co-occurring CUD (n = 1820, 84.73% men, mean age 26.80 years, SD 8.25 years). The main outcome was hospitalization due to psychotic relapse. Hospitalization due to any psychiatric disorder or substance use disorder (SUD) were examined as secondary outcomes. Within-individual Cox regression models were used to study these associations. Study Results Use of any antipsychotic was associated with a 33% risk reduction of psychotic relapse (aHR = 0.67; 95% CI 0.60–0.75). Clozapine (0.43; 0.29–0.64), long-acting injectable (LAI) formulations of risperidone (0.40; 0.22–0.71), aripiprazole (0.42; 0.27–0.65), and paliperidone (0.46; 0.30–0.69) were associated with the lowest risk of relapse. The association between the LAI formulation of olanzapine and hospitalization due to psychosis was statistically non-significant (0.61; 0.35–1.05). Clozapine was associated with an 86% risk reduction of hospitalization due to SUD (0.14; 0.05–0.44). Of oral non-clozapine antipsychotics, aripiprazole was associated with the lowest risk of hospitalization due to psychotic relapse (0.61; 0.45–0.83). Conclusions These findings support the use of clozapine, LAI formulations of second-generation antipsychotics other than olanzapine, or oral aripiprazole to prevent hospitalization in FEP and co-occurring CUD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Faculty of Medicine, University of Turku, Turku, Finland.
- Addiction Psychiatry Unit, Department of Psychiatry, Turku University Hospital, The Wellbeing Services County of Southwest Finland, Turku, Finland.
- Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
- Department of Social Genetics and Developmental Psychiatry, IoPPN, King's College London, London, England.
ORCID-Profile: Heidi Taipale, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Antti Mustonen
Förderung
- Swedish Research Council
Zitieren
APA
Denissoff, A., Taipale, H., Tiihonen, J., Di Forti, M., Mittendorfer-Rutz, E., Tanskanen, A., Mustonen, A., & Niemelä, S. (2024). Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbae034
Vancouver
Denissoff A, Taipale H, Tiihonen J, Di Forti M, Mittendorfer-Rutz E, Tanskanen A, et al. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study. Schizophrenia Bulletin. 2024. doi:10.1093/schbul/sbae034
BibTeX
@article{Denissoff2024,
author = {Denissoff, Alexander and Taipale, Heidi and Tiihonen, Jari and Di Forti, Marta and Mittendorfer-Rutz, Ellenor and Tanskanen, Antti and Mustonen, Antti and Niemelä, Solja},
title = {Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study},
journal = {Schizophrenia Bulletin},
year = {2024},
doi = {10.1093/schbul/sbae034}
}
EUVIMED